Reducing processing risks & operational challenges for low volume fluid transfer

Cell & Gene Therapy Insights 2022; 8(3), 353;


Published: 28 March 2022
Troy Ostreng, Jayanthi Grebin

Watch the video or read the poster to learn about:

  • Challenges and risks in low volume fluid transfer
  • Limitations of traditional methods for connecting tubing (e.g., making connections under a laminar flow hood; tube welding)
  • Advantages in utilizing sterile connectors as an alternative method for the advanced therapies industry

Troy Ostreng, is the Senior Product Manager for the MicroCNX™ connector technology at CPC. Troy has 20+ years experience in polymer design, technical engineering, project management, and business development in several different industries with the last 5+ years focusing in new product development for single-use technology in the Biopharmaceutical and Cell and Gene market. His experience and expertise are helping CPC to develop connection technology further accelerating innovation in the single-use manufacturing space.

Jayanthi Grebin has 15 years of experience in the Bioprocessing market as a Business Development Manager, Product Manager and Application engineer, focusing on single use technology. The last 10 years have been focused on new product development, new applications, and new markets within the Bioprocessing, Biotechnology and Cell and Gene Therapy markets. She has been a key contributor and influencer of new product development in Bioprocessing for single use film, connectors, molding, sensors, and tubing at companies like ATMI, Pall and Entegris.